Last month, former President Joe Biden announced that he had been diagnosed with an aggressive form of prostate cancer. The news sparked a larger conversation about what exactly the best practices are to screen for prostate cancer. Turns out, it’s more complicated than it might seem. Host Ira Flatow is joined by oncologist Matthew Cooperberg and statistician Andrew Vickers, who studies prostate cancer screening, to help unpack those complexities.
Guests:
Dr. Matthew Cooperberg, urologic oncologist and professor at the University of California, San Francisco
Dr. Andrew Vickers, statistician studying the efficacy of prostate cancer screening at Memorial Sloan Kettering Cancer Center in New York City
Guests:
Dr. Matthew Cooperberg, urologic oncologist and professor at the University of California, San Francisco
Dr. Andrew Vickers, statistician studying the efficacy of prostate cancer screening at Memorial Sloan Kettering Cancer Center in New York City
- Category
- Oncology

Be the first to comment